These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38532522)

  • 21. Cholinergic symptoms and QTc prolongation following donepezil overdose.
    Pourmand A; Shay C; Redha W; Aalam A; Mazer-Amirshahi M
    Am J Emerg Med; 2017 Sep; 35(9):1386.e1-1386.e3. PubMed ID: 28668178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of acute cholinergic adverse effects induced by donepezil overdose: a follow-up of clinical course and plasma concentration of donepezil].
    Yano H; Fukuhara Y; Wada K; Kowa H; Nakashima K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):482-6. PubMed ID: 14658400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extrapyramidal side effect of donepezil hydrochloride in an elderly patient: A case report.
    Li HC; Luo KX; Wang JS; Wang QX
    Medicine (Baltimore); 2020 Mar; 99(11):e19443. PubMed ID: 32176074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donepezil for dementia due to Alzheimer's disease.
    Birks JS; Harvey RJ
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease.
    Jia J; Wei C; Chen W; Jia L; Zhou A; Wang F; Tang Y; Xu L
    J Alzheimers Dis; 2020; 74(1):199-211. PubMed ID: 31985467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.
    Rogers SL
    Dement Geriatr Cogn Disord; 1998; 9 Suppl 3():29-42. PubMed ID: 9853200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.
    Hernandez RK; Farwell W; Cantor MD; Lawler EV
    J Am Geriatr Soc; 2009 Nov; 57(11):1997-2003. PubMed ID: 19793162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.
    Prescrire Int; 2011 Apr; 20(115):95. PubMed ID: 21648211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A large, community-based, open-label trial of donepezil in the treatment of Alzheimer's disease.
    Relkin NR; Reichman WE; Orazem J; McRae T
    Dement Geriatr Cogn Disord; 2003; 16(1):15-24. PubMed ID: 12714795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: a pilot study.
    Castellino SM; Tooze JA; Flowers L; Hill DF; McMullen KP; Shaw EG; Parsons SK
    Pediatr Blood Cancer; 2012 Sep; 59(3):540-7. PubMed ID: 22238217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donepezil-induced adverse side effects of cardiac rhythm: 2 cases report of atrioventricular block and Torsade de Pointes.
    Tanaka A; Koga S; Hiramatsu Y
    Intern Med; 2009; 48(14):1219-23. PubMed ID: 19602789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview].
    Voss B; Thienel R; Leucht S; Kircher T
    Nervenarzt; 2008 Jan; 79(1):47-8, 50-2, 54-9. PubMed ID: 17960354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donepezil in the treatment of ischemic stroke: Review and future perspective.
    Barfejani AH; Jafarvand M; Seyedsaadat SM; Rasekhi RT
    Life Sci; 2020 Dec; 263():118575. PubMed ID: 33058916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylcholinesterase inhibitor donepezil in the treatment of cognitive deficit in schizophrenia. Subanalysis of the active branch from Czech extended double blind study.
    Pérez M; Tůma I; Pytela O; Kadlecová E; Zemanová M; Lenderová Z
    Eur Psychiatry; 2006 Dec; 21(8):548-50. PubMed ID: 16797936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donepezil in schizophrenia--is it helpful? An experimental design case study.
    MacEwan GW; Ehmann TS; Khanbhai I; Wrixon C
    Acta Psychiatr Scand; 2001 Dec; 104(6):469-72. PubMed ID: 11782241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of donepezil added to atypical antipsychotics on cognition in patients with schizophrenia: an open-label trial.
    Chung YC; Lee CR; Park TW; Yang KH; Kim KW
    World J Biol Psychiatry; 2009; 10(2):156-62. PubMed ID: 19514097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and tolerability of donepezil 23 mg with or without intermediate dose titration in patients with Alzheimer's disease taking donepezil 10 mg: a multicenter, randomized, open-label, parallel-design, three-arm, prospective trial.
    Hong YJ; Han HJ; Youn YC; Park KW; Yang DW; Kim S; Kim HJ; Kim JE; Lee JH;
    Alzheimers Res Ther; 2019 May; 11(1):37. PubMed ID: 31039806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential cardiotoxic reaction involving rivastigmine and beta-blockers: a case report and review of the literature.
    Paulison B; Léos CL
    Cardiovasc Toxicol; 2010 Dec; 10(4):306-10. PubMed ID: 20865460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donepezil-induced mania.
    Leung JG
    Consult Pharm; 2014 Mar; 29(3):191-5. PubMed ID: 24589768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute inability to mobilise resulting from probable donepezil-induced myoclonus.
    Whateley JM; Huffman AJ; Henderson EJ
    Age Ageing; 2018 Nov; 47(6):907-908. PubMed ID: 29939205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.